UK and Gulf States Sign Historic Trade Deal Expected to Add Billions to the Economy Stellantis Turnaround Plan Prediction Market Regulation Oura IPO Filing Key Market Developments SP 500 Rises on Tech and Healthcare Strength Communication Services Lags Ferrari Faces Investor Backlash Over First Electric Model Luce Bloom Energy Shares Surge After 26 Billion FuelCell Deal With AI Data Center Builder Nebius OIG Report Criticizes USP Canaan Prison Conditions Systemic Issues May Drive Policy Reform UTI Q1 2026 Earnings EPS Misses Estimates Stock Rises on Potential Optimism BRBI Q1 2026 Earnings Significant EPS Miss Amid Challenging Environment RIOT Q1 2026 Earnings EPS Lags Consensus by Wide Margin Stock Climbs 037 Despite Miss PRVA Q1 2026 Earnings EPS Miss Puts Focus on Cost Management and Growth Trajectory Armlogi Holding Corp BTOC Q4 2025 Earnings Net Loss Reported Amid Limited Disclosures SIMO Q1 2026 Earnings EPS Surges 178 Above Estimates But Stock Declines Global Payments GPN Edges Higher Navigating Support and Resistance Levels Assured Guaranty Ltd AGO Retreats 226 Amid Broader Market Pressure Airship AI Holdings Warrants Dip 3 as Support Level Comes into Focus MFS Municipal Income Trust CMU Holds Steady Near Support Amid Modest Gains Fundrise Innovation Fund VCX Falls 476 Testing Key Support Levels New Tax Season Changes Online Sellers and EV Buyers May Find Savings MNST Q1 2026 Earnings EPS Beats Estimates as Company Delivers Strong Profitability Vail Resorts MTN Exhibits Strength as Shares Rebound 358 Galectin Therapeutics Q1 2026 Earnings EPS Misses Estimates Stock Rallies on Operational Progress Corebridge Financial CRBG Q1 2026 Earnings EPS Misses by a Hair Stock Edges Higher FOXF Q1 2026 Earnings EPS Surges 115 Above Estimates Stock Rises UXIN Q1 2025 Earnings Loss Per Share Reported Amidst Market Challenges THRM Q1 2026 Earnings EPS Crushes Estimates with 625 Surprise LNC Q1 2026 Earnings EPS Surpasses Estimates Despite Absent Revenue Disclosure PDS Biotechnology Q1 2026 Earnings Narrowed Loss Per Share and Clinical Progress Drive Positive Market Response